Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial
M. Eugenia Socías(University of British Columbia), Nadia Fairbairn(British Columbia Centre on Substance Use), Paxton Bach(University of British Columbia), Rupinder Brar(Vancouver Coastal Health), Sean M. Murphy(Cornell University), Evan Wood(University of British Columbia), Huiru Dong(St. Paul's Hospital)
Cited by 19
Related Papers
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation
|Inflammatory Bowel Diseases|2019|426
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148
<i>Cryptococcus gattii</i>Dispersal Mechanisms, British Columbia, Canada
|Emerging infectious diseases|2007|146